For decades, women across the U.S. regularly used talc-based Johnson & Johnson Baby Powder and Shower to Shower products believing they were safe. Today, tens of thousands of women and families have filed J&J talcum powder lawsuits alleging these products caused ovarian cancer.
Although some plaintiffs have secured multi-million-dollar verdicts and settlements, trial results show the more than 67,000 remaining lawsuits are highly unpredictable.
Most recently, the second test trial involving ovarian cancer lawsuits and J&J’s talcum powder products ruled in favor of the product manufacturer.
The plaintiffs were the families of three women who died from ovarian cancer, which they alleged was caused by certain Johnson & Johnson products. Jurors determined the evidence presented didn’t prove the claim that talc powder contributed to the women’s injuries.
So far, these product liability and wrongful death cases have been largely inconsistent. From billion-dollar verdicts and multi-million-dollar settlements, to failed bankruptcy protection and overturned and reduced verdicts, the talc baby powder lawsuits are proving to be anything but guaranteed for either side.
Mixed Results in the Talc Baby Powder Bellwether Trials
The second test trial involving Johnson & Johnson’s baby powder played out far differently than the first. In December 2025, the first bellwether case in the talc ovarian cancer litigation resulted in a $40 million verdict for the plaintiffs, who alleged they weren’t warned of the risks. Jurors found that J&J’s baby powder substantially contributed to causing the two women’s ovarian cancer.
The ruling sparked hope among many of the more than 67,000 women and surviving family members who have waited years, many for more than a decade, for their lawsuits to move forward. But J&J securing a win in the second bellwether trial has reinforced that a win for one does mean that others will get the same result.
For the individuals who have filed individual J&J ovarian cancer lawsuits and the more than 67,000 plaintiffs that are part of the federal multidistrict litigation (MDL), the mixed case outcomes are significant for several reasons.
Sometimes, bellwether trials result in one side winning more cases than the other. When plaintiffs secure more verdicts, it shows their evidence and arguments hold up in court, putting pressure on defendants to settle. But when defendants are more successful, they gain leverage at the negotiating table and settlement amounts usually end up being lower.
At this point, neither party in the talc ovarian cancer lawsuits has substantial leverage. And while many plaintiffs have secured major wins in court and through negotiations, J&J has increasingly succeeded in defending individual cases and overturning earlier verdicts on appeal.
Can Women Still File Johnson & Johnson Talc Lawsuits?
It’s not too late for women to file a talc powder lawsuit against J&J. Despite years of litigation and settlement discussions, many who developed ovarian cancer after prolonged use of Johnson & Johnson’s talcum powder products still have legal options.
Surviving spouses, children, and other family members may also be able to pursue wrongful death claims depending on state law. But because statutes of limitations vary, waiting too long can hurt talc ovarian cancer cases and even prevent claims from being filed.
Some of the key factors that make baby powder lawsuits against Johnson & Johnson so complex and difficult to prove is how long it’s been since many women used the products. Receipts of purchase no longer exist, witnesses die and memories fade, and family members often don’t know which products were used.
Anyone who thinks they may have developed ovarian cancer because they used talc baby powder should speak with a product liability attorney.
Why Some Talc Ovarian Cancer Plaintiffs Win
Ovarian cancer baby powder lawsuits are highly individualized. Plaintiffs generally rely on studies suggesting that long-term genital use of talcum powder is associated with an increased risk of ovarian cancer. They also present internal company documents and expert testimony concerning asbestos contamination in talc and product safety.
But there are legal hurdles to overcome because plaintiffs didn’t develop ovarian cancer immediately after using J&J’s baby powder. It took years, often more than a decade, for women to be diagnosed.
Proving the cause, collecting medical records, and successfully arguing that scientific research supports plaintiffs’ claims is no easy feat. The absence of product receipts and lack of documented proof of exactly how often they used talc baby powder affects these cases.
Defense attorneys repeatedly challenge whether a woman's cancer was caused by the baby powder or other factors, such as age, genetics, obesity, hormone exposure, or family history. They also point to studies that show no correlation between their product and ovarian cancer.
As a result, jurors often hear conflicting scientific opinions, which explains why verdicts vary dramatically.
Timeline of Major J&J Talc Verdicts and Settlements
Johnson & Johnson has attempted to resolve the majority of ovarian cancer claims three times through global settlement proposals. At the same time, the talc baby powder lawsuits have produced some of the largest verdicts in product liability history.
The history of major J&J talc verdicts and settlements include:
· 2018: $4.7 billion Missouri verdict for 22 women who filed ovarian cancer lawsuits.
· 2020: $100 million settlement involving more than 1,000 plaintiffs.
· 2023: $8.9 billion settlement proposal.
· 2024: $6.475 billion settlement proposal.
· 2025 (March): Nearly $10 billion global bankruptcy proposal.
· 2025 (December): $40 million verdict for the plaintiffs in the first bellwether trial.
· 2026 (June): J&J wins second bellwether trial.
The three multi-billion-dollar settlement proposals between 2023 and 2025 were all rejected.
Many of the substantial verdicts involved allegations that Johnson & Johnson knew about concerns surrounding talc safety but failed to adequately warn consumers. Internal company documents introduced during trials have played a significant role in several plaintiff victories.
Research Links Talcum Powder to Ovarian Cancer
Plaintiffs who filed baby powder lawsuits have relied heavily on research studies that found a connection between long-term talc use and ovarian cancer. Several studies dating back to the 1980s suggest ovarian cancer risks were higher for women who regularly used talcum powder in the genital area.
Another factor impacting the J&J talc lawsuits is that the International Agency for Research on Cancer (IARC) classified talc as "probably carcinogenic to humans” in 2024. As part of the World Health Organization, such classification carries weight, as it was based on considerable research.
Many baby powder cases have focused on allegations of asbestos contamination in talc products, which was at the center of mesothelioma lawsuits against J&J.
Between contradictory evidence, exposure timeline, and other factors affecting the product liability litigation, Johnson & Johnson talc powder lawsuits are being closely watched. While progress has been show, with tens of thousands of people who have suffered from or lost loved ones to ovarian cancer, the outcome of cases will have widespread ramifications.
